Artiva Biotherapeutics said Tuesday that it’s winding down after two patients died in a trial testing its cell therapy for autoimmune diseases, the latest in a series of safety events that emerged in a promising […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla. […]
There’s a boy like you in Minnesota, Yannick’s mom told him a few years ago. He has the same disease. He has the same kind of smile. Maybe you could talk? They clicked. After school […]
SAN DIEGO — Two years ago, Tala Fakhouri was writing AI policy at the Food and Drug Administration. Now, after leaving the FDA last summer, she’s getting a firsthand look at how the industry is […]
SAN DIEGO — On the exhibition floor at the annual international BIO conference in San Diego, biotech and startup executives hummed around pavilions representing member countries and states, pausing to watch World Cup games on […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Several of my colleagues are at the BIO conference in San Diego […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Pharma companies are on a biotech buying spree, an LSD pill just […]
SAN DIEGO — Revolution Medicines is already cooking up the next iteration of RAS inhibiting drugs. At the American Association of Cancer Research annual meeting here, the company is the talk of the town for […]
SAN DIEGO — Alison Cameron spent close to a decade fighting to keep myeloma under control. She’d been diagnosed with smoldering multiple myeloma, a precursor to cancer, and spent years receiving infusions to keep it […]
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its […]
Illumina became a genomics juggernaut by developing machines that could read large amounts of DNA accurately and quickly. But the company’s betting the next phase of its growth will be accelerated by helping customers better […]
WASHINGTON — George Tidmarsh, the Food and Drug Administration’s top regulator of drugs, has been placed on administrative leave after being accused of using his regulatory authority to inflict financial harm on a former business associate, […]
CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]
DNA sequencing giant Illumina announced Thursday that it would enter the field of drug discovery, a major shift for a company that, since its founding in 1998, has thrived instead by selling picks and shovels […]
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have found his way to the life sciences industry. As he’ll tell you, he wasn’t on the traditional path to becoming […]
Guest Author: Sudip Parikh, Senior Vice President & Managing Director, Americas at DIA Global* I had a great experience as a Scripps Research graduate student in La Jolla. After graduating, I moved to the east […]
The biggest question in entrepreneurship is how does one take an idea and make it reality, make it something that?s tangible and positively affects an individual and society as a whole. This was the theme […]
Here at SDBN we?ve been updating our directory of 400+ San Diego biotech companies.? We were surprised to find close to 40 companies removed from the local scene ? due to acquisition or shut down.? […]
Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been […]
The Pathway Genomics business model is based on bridging a gap in personalized medicine.? As Ed MacBean, their VP of Product Development, explained at SDBN?s August 16th event, in a nutshell they connect clients through […]
Thanks to everyone who took our 2011 poll, the results are IN! See the slideshare presentation below which summarizes the results. Check out the word cloud based on the essay answers, with largest words representing […]
2011 is a new year for San Diego Biotech and we’re hoping that the good news will outweigh the bad. Let’s start off featuring a great company with a long history of success in the […]
Wednesday I attended a regenerative medicine-focused breakfast at the BIO convention and learned about San Diego company Advanced BioHealing (ABH), who took a ‘fallen’ asset, Dermagraft, and not only turned it into an $85M/year product, […]
On the San Diego Biotechnology Network LinkedIn group, we asked you what you wanted to hear about from the BIO Convention in Chicago, and you requested to hear about Biomarkers. Tuesday I attended a breakout […]
Drug development is an area that, according to our 2010 poll, you are interested in, and in previous meetings we’ve discussed that San Diego biotech could grow if we would better complement our drug discovery […]
Copyright © 2026 Biotech Networks, LLC
